Anda belum login :: 23 Nov 2024 01:17 WIB
Home
|
Logon
Hidden
»
Administration
»
Collection Detail
Detail
Performance evaluation of bio-medical industry in Taiwan
Oleh:
Hsu, Kai-Chen
;
Wen, Ching-Chih
;
Phoomborplub, Worapong
Jenis:
Article from Proceeding
Dalam koleksi:
Proceeding IConEnt 2016 (International Conference on Entrepreneurship) : How Innovation could Improve the Performance and Productivity in Entrepreneurship?
,
page 1-6.
Topik:
Bio-medical Industry
;
Performance Evaluation
;
OTC
;
Data Envelopment Analysis.
Fulltext:
Kai-Chen Hsu, Ching-Chih Wen, Worapong Phoomborplub.pdf
(215.29KB)
Isi artikel
Recently, within these 20 years, the industry of biotechnology and medical (bio-medical or bio-med) in Taiwan has developed properly, thanks to the efforts of the government and experts in the industry. At the end of 2014 there had been 27 listed bio-med companies and 60 OTC traded bio-medical companies. These companies focus on medicines manufacturing, therapeutic equipment and the application of bio-tech. Investigating new products and applying new patents are the main factors for the bio-tech industry to profit and to have privilege of competing. Each company invests capital into investigating new products hoping to increase sales performance in order to gain privilege of competing. The research is interested to see which branch of bio-med companies has better performance and the importance of research and development (R&D). This research investigates the bio-med industry by using data envelopment analysis as a tool and focus on product development and management performance. Thirteen listed companies in Taiwan were chosen for the study. Results show there is significant performance difference between different bio-med company branches. Study shows the company focusing on therapeutic equipments has a better performance. However, there is no significant relationship between R&D and sales performance.
Opini Anda
Klik untuk menuliskan opini Anda tentang koleksi ini!
Kembali
Process time: 0.015625 second(s)